Heart Failure Reviews

Papers
(The TQCC of Heart Failure Reviews is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Imaging techniques for the assessment of adverse cardiac remodeling in metabolic syndrome72
Comprehensive approach to cardiac amyloidosis care: considerations in starting an amyloidosis program65
Trends and complications associated with acute new-onset heart failure: a National Readmissions Database–based cohort study46
Prognostic value of natriuretic peptides in heart failure: systematic review and meta-analysis42
Validation of the MEDIA echo score for the prognosis of heart failure with preserved ejection fraction41
Severe low-gradient aortic stenosis: impact of inadequate left ventricular responses to high afterload on diagnosis and therapeutic decision-making40
Polypharmacy definition and prevalence in heart failure: a systematic review39
Amyloid seeding as a disease mechanism and treatment target in transthyretin cardiac amyloidosis36
Clinical variants of myocardial involvement in COVID-19-positive patients: a cumulative experience of 202036
Right ventricular failure: a comorbidity or a clinical emergency?34
The cardiosplenic axis: the prognostic role of the spleen in heart failure33
Fibrosis in hypertrophic cardiomyopathy: role of novel echo techniques and multi-modality imaging assessment32
Can mechanical circulatory support be an effective treatment for HFpEF patients?31
Device therapy with interatrial shunt devices for heart failure with preserved ejection fraction30
Correction to: Is it time to revisit ICD indications?28
A systematic review exploring the significance of measuring epicardial fat thickness in correlation to B-type natriuretic peptide levels as prognostic and diagnostic markers in patients with or at ris28
The role of TAVR in patients with heart failure: do we have the responses to all questions?28
Cardiovascular magnetic resonance for suspected cardiac amyloidosis: where are we now?26
Atrial fibrillation-induced tachycardiomyopathy and heart failure: an underappreciated and elusive condition26
Advanced cardiovascular multimodal imaging and aortic stenosis24
Dependence and reduced motor function in heart failure: future directions for well-being24
Cardiac 31P MR spectroscopy: development of the past five decades and future vision—will it be of diagnostic use in clinics?24
Mechanisms, time course and predictability of premature ventricular contractions cardiomyopathy—an update on its development and resolution24
Exosomes in atrial fibrillation: therapeutic potential and role as clinical biomarkers24
The protective effects of 17-β estradiol and SIRT1 against cardiac hypertrophy: a review24
Peripartum cardiomyopathy: a review22
Clinical management of amyloid cardiomyopathy19
Filamin C in cardiomyopathy: from physiological roles to DNA variants18
Resistance training in heart failure patients: a systematic review and meta-analysis17
MicroRNAs in hypertrophic cardiomyopathy: pathogenesis, diagnosis, treatment potential and roles as clinical biomarkers17
The non-invasive assessment of myocardial work by pressure-strain analysis: clinical applications17
Speckle tracking echocardiography in heart failure development and progression in patients with apneas17
Advanced airway management and respiratory care in decompensated pulmonary hypertension16
Neuromuscular diseases and their cardiac manifestations under the spectrum of cardiovascular imaging16
Osteoprotegerin and RANKL-RANK-OPG-TRAIL signalling axis in heart failure and other cardiovascular diseases16
0.13609790802002